Jonathan C. Huang

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Manfred von der Ohe, A. Coates, C. Trautwein, 2019, The Lancet.

Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.

J. Chan, D. Rockey, P. Thuluvath, 2020, Journal of hepatology.

Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.

E. Gane, D. Brainard, R. Robson, 2020, The lancet. Gastroenterology & hepatology.

Recipient survival and graft survival are not diminished by simultaneous liver‐kidney transplantation: An analysis of the united network for organ sharing database

J. Klein, K. Saeian, J. Bajaj, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

Michael I. Miller, R. Andrade, F. Nevens, 2019, Journal of Hepatology.

Chapter Ammonia

Jonathan C. Huang, Edwin J. Lee, 2019 .